{"nct_id":"NCT02159040","title":"Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.","status":"TERMINATED","status_verified_date":"2017-03","start_date":"2014-09-11","start_date_type":"ACTUAL","primary_completion_date":"2015-06-26","primary_completion_date_type":"ACTUAL","completion_date":"2015-06-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}